Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
September 15th, 2014
62.9K views
Here we demonstrate a technique for widespread neuronal transduction by intraventricular injection of adeno-associated virus into the neonatal mouse brain. This method provides a rapid and easy way to attain lifelong expression of virally-delivered transgenes.
Overview
This article demonstrates a technique for widespread neuronal transduction through intraventricular injection of adeno-associated virus into the neonatal mouse brain. This method allows for rapid and easy attainment of lifelong expression of virally-delivered transgenes.
Key Study Components
Area of Science
- Neuroscience
- Gene Therapy
- Neurobiology
Background
- Viral transduction is a method used to deliver genes into cells.
- Adeno-associated virus (AAV) is commonly used for gene delivery in neuroscience.
- Neonatal mice are often used as models for studying brain development.
- Accurate targeting of brain regions is crucial for effective transduction.
Purpose of Study
- To develop a reliable method for targeting the lateral ventricles in neonatal mice.
- To achieve widespread expression of transgenes in the brain.
- To facilitate future studies on gene function and neural circuitry.
Methods Used
- Cryo-anesthetization of newborn pups.
- Identification of the injection site for targeting the lateral ventricles.
- Insertion of a needle to the correct depth for virus infusion.
- Infusion of up to two microliters of virus solution into each lateral ventricle.
Main Results
- Successful transduction of neurons throughout the brain.
- Demonstration of transgene expression patterns using fluorescent tags.
- Identification of challenges faced by beginners in targeting the lateral ventricles.
- Establishment of a protocol for future applications in neuroscience research.
Conclusions
- The intraventricular injection method is effective for neuronal transduction.
- This technique can be used to study gene function in the brain.
- Further refinement of targeting techniques may improve outcomes for researchers.
Frequently Asked Questions
What is the main goal of this procedure?
The main goal is to virally transduce neurons throughout the brain.
What virus is used for transduction?
Adeno-associated virus (AAV) is used for transduction.
How is the injection site identified?
The injection site is located between the Lambda suture and each eye or laterally from the sagittal suture.
What is the volume of virus solution injected?
Up to two microliters of virus solution is infused into each lateral ventricle.
What is used to visualize transgene expression?
A fluorescent tag or immunofluorescence is used to show transgene expression patterns.
What challenges do beginners face with this technique?
Beginners often struggle with accurately targeting the lateral ventricles.
Executive Industry Relevance
This technique enables rapid, lifelong transgene expression in the neonatal mouse brain, supporting early-stage target validation and mechanistic de-risking in neuroscience drug discovery. By achieving widespread neuronal transduction with minimal surgical complexity, it reduces reliance on germline models and accelerates in vivo functional genomics workflows. The approach offers a scalable, cost-effective platform for probing gene function in disease-relevant neural circuits during discovery.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through widespread neuronal transgene expression across multiple brain regions.
- Operational Value: Provides a rapid, reproducible method for functional target validation without germline engineering timelines.
- Predictive Value: Supports phenotypic screening in disease-relevant systems by modulating gene expression in developing neural circuits.
Screening & Assay Development
- Assay Readiness: Generates validated neuronal models with fluorescent reporters for quantitative imaging-based readouts.
- Scalability: Compatible with viral core facilities for high-throughput preparation of custom AAV constructs.
- Quantitative Control: Allows titration of viral titer to modulate transduction density and expression mosaicism for dose-response modeling.
Translational & Preclinical Research
- Disease Relevance: Supports studies in neurodevelopmental and neurodegenerative models by targeting neurons during critical postnatal windows.
- Translational Continuity: Enables persistent transgene expression from neonatal stages through adulthood, aligning with longitudinal preclinical studies.
- Mechanistic De-risking: Facilitates co-expression of multiple transgenes to probe pathway interactions and target specificity.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target identification to lead optimization, enabling in vivo functional assessment prior to compound screening.
- Discovery Biology: Supports hypothesis testing and pathway clarification via neuron-wide transgene delivery in intact neural circuits.
- Screening: Produces standardized, fluorescently labeled neuronal populations for automated imaging and phenotypic analysis.
- Analytics: Enables quantitative comparison of transduction efficiency and expression patterns across viral titers and serotypes.
- Translational Research: Connects early gene manipulation to sustained phenotypic readouts in mature animals.
- Enterprise Reuse: Establishes a reusable platform for serial gene targeting studies across multiple targets and disease areas.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in neuronal gene function studies.
- Operational Value: Enhances reproducibility through standardized cryo-anesthesia and stereotaxic-adaptable injection protocols.
- Strategic Value: Improves capital efficiency by lowering costs and timelines compared to transgenic model generation.
- Portfolio Impact: Enables risk-adjusted target prioritization through rapid in vivo validation of molecular targets.
Implementation Considerations
- Requires expertise in neonatal mouse handling and microsurgical techniques.
- Dependent on sterile microsyringes, viral preparations, and temperature-controlled platforms.
- Necessitates cross-team standardization for consistent ventricular targeting across operators.
- Adaptation considerations include varying viral serotypes, promoters, and transgene cargo sizes.
- Practical limitations include anatomical constraints in postnatal day zero pups and variability in ventricular access.
Biopharma FAQs
Why is cryo-anesthetization used before ventricular injection?
Cryo-anesthetization induces hypothermia to immobilize neonatal pups without pharmacological agents, ensuring stable positioning for accurate ventricular targeting. This method avoids respiratory depression risks associated with injectable anesthetics in neonates. It enables reproducible surgical conditions critical for successful viral delivery into the lateral ventricles.
How does viral titer influence transgene expression density in the brain?
Viral titer directly controls the degree of transgene mosaicism, with higher concentrations (10^7 to 10^10 particles/mL) yielding dense labeling and lower titers producing sparse expression. This titration allows researchers to model dosage-dependent effects and avoid overexpression artifacts. Adjusting titer enables scalable control over transduction efficiency for experimental design flexibility.
What enables widespread neuronal transduction following intraventricular AAV delivery?
The immature ependymal lining in neonates allows AAV to diffuse freely from the ventricles into the brain parenchyma, facilitating broad neuronal uptake. This developmental window (first 12–24 hours post-birth) is essential for achieving widespread transduction across regions like cortex, hippocampus, and cerebellum. The method exploits this transient biological property to achieve pan-neuronal labeling without multiple injection sites.
Why is fluorescent co-expression critical for validating transduction success?
Fluorescent tags (e.g., YFP, tdTomato) provide direct, vital labeling of transduced cells, enabling immediate visualization of expression patterns without histological processing. This allows rapid confirmation of injection accuracy and transgene spread in live or fixed tissue. Co-expression supports quantitative analysis of transduction efficiency and mosaicism across experimental conditions.
How does stereotaxic adaptation improve injection consistency for novice users?
Stereotaxic frames provide standardized coordinates (0.8 mm lateral, 1.5 mm anterior to lambda) to improve targeting accuracy of the lateral ventricles. This reduces reliance on anatomical landmarks visible through skin, minimizing variability between operators. The adaptation enhances reproducibility and success rates, particularly for researchers new to neonatal intracranial procedures.
Chapters in this video
0:05
Title
1:24
Staging the Newborn Pups for Injection
2:38
Free-hand Intracranial Injection of AAV into Neonatal Mice
4:54
Stereotaxic Injection of AAV into Neonatal Mice
7:21
Post-injection Care
7:54
Effect of Viral Titer and Serotype on VIral Transduction and Co-expression
9:55
Conclusion
